Researchers focus on genetic mutations to treat Crohn's disease

04/27/2010 | Wall Street Journal, The

U.S. researchers are examining genetic mutations linked to Crohn's disease, ulcerative colitis and other irritable bowel conditions in hopes of developing personalized treatments based on stem cells. They hope to use induced pluripotent stem cells to repair the NOD2 genetic mutation that is related to Crohn's.

View Full Article in:

Wall Street Journal, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice President - Government Products
Health Alliance Plan
Detroit, MI
Director, Compliance - Health Plan Privacy & Security
Kaiser Permanente
Oakland, CA
Chief Medical Officer
Nashville, TN
Commercial Health Insurance Strategist__Job #52-14
American Academy of Family Physicians
Leawood, KS
Manager of Payer Relations
Pharmacy Quality Solutions, Inc.
Raleigh/Durham, NC